Exelixis, Inc. (EXEL)
49.83
-0.30
(-0.60%)
USD |
NASDAQ |
May 18, 15:40
Exelixis Total Liabilities (Quarterly) : 657.84M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 82.75B |
| Madrigal Pharmaceuticals, Inc. | 683.87M |
| Krystal Biotech, Inc. | 120.24M |
| Arcus Biosciences, Inc. | 473.00M |
| Immunome, Inc. | 31.11M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.594B |
| Shareholders Equity (Quarterly) | 1.936B |
| Debt to Equity Ratio | 0.0876 |
| Current Ratio | 3.258 |
| Net Debt Paydown Yield | 0.09% |